## AMP: Ameriprise Financial, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 3.1% below STRENGTH zone (4.0-10.0%); PEG 1.73 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($479.77)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Ameriprise Financial (NYSE:AMP) Stock Price Expected to Rise, Morgan Stanley Analyst Says**
- Source: MarketBeat | 20251222T174229 | Neutral | Relevance: 100%
- Morgan Stanley increased its price target on Ameriprise Financial (NYSE:AMP) to $485, despite maintaining an "underweight" rating, suggesting a slight downside. The consensus among analysts is a "Hold" with an average price target of $533.33, reflecting mixed opinions and recent target reductions. Ameriprise recently surpassed quarterly earnings and revenue expectations, and the stock is currently trading below its 12-month high.

**2. Morgan Stanley Maintains Ameriprise Financial (AMP) Underweight Recommendation**
- Source: Nasdaq | 20251223T000750 | Somewhat-Bearish | Relevance: 100%
- Morgan Stanley has reaffirmed its "Underweight" recommendation for Ameriprise Financial (AMP). Despite this, the average one-year price target for AMP suggests an 11.23% upside from its current trading price, with forecasts ranging from $438.34 to $685.65. Institutional ownership has seen a slight decrease in the last quarter, yet the put/call ratio indicates a bullish sentiment for the stock.

**3. Voya Investment Management LLC Has $35.24 Million Position in Ameriprise Financial, Inc. $AMP**
- Source: MarketBeat | 20251221T122248 | Neutral | Relevance: 100%
- Voya Investment Management LLC significantly reduced its stake in Ameriprise Financial, Inc. (NYSE:AMP) by 33.5% in the third quarter, now holding 71,733 shares valued at approximately $35.24 million. Other institutional investors made various changes to their positions, with overall institutional ownership reaching 83.95%. Analysts currently give Ameriprise Financial a "Hold" rating with a consensus price target of $533.22.

**4. Morgan Stanley Adjusts PT on Ameriprise Financial to $485 From $484, Maintains Underweight Rating**
- Source: marketscreener.com | 20251222T111634 | Somewhat-Bearish | Relevance: 95%
- Morgan Stanley has adjusted its price target for Ameriprise Financial (AMP) to $485 from $484, while maintaining an "Underweight" rating on the stock. This update reflects a slight change in the analyst's valuation of the company. Ameriprise Financial specializes in investment services, wealth management, asset management, and insurance.

**5. Arvest Investments Inc. Decreases Stock Position in Goldman Sachs Access Treasury 0-1 Year ETF $GBIL**
- Source: Defense World | 20251222T080943 | Somewhat-Bullish | Relevance: 65%
- Arvest Investments Inc. reduced its stake in the Goldman Sachs Access Treasury 0-1 Year ETF (NYSEARCA:GBIL) by 30.8% during the third quarter, now holding 16,411 shares valued at approximately $1,645,000. Despite this reduction, other institutional investors like Cresset Asset Management LLC, Raymond James Financial Inc., Ameriprise Financial Inc., Northwestern Mutual Wealth Management Co., and Synovus Financial Corp. increased their holdings in the ETF. The Goldman Sachs Access Treasury 0-1 Year ETF, which invests in US Treasury securities with less than one year maturity, opened at $100.17 and has a 50-day simple moving average of $100.07.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $485 | $484 | +0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 1 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.3% (-0.5%)
- JPMORGAN CHASE & CO: 10.3% (+53.2%)
- Blackrock Inc.: 9.7% (-5.2%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 3.1% (+0.8%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.73 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 60%, margin 20%). Balance sheet: strong liquidity (308.1x), $2.2B free cash flow. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $47.0B |
| Beta | 1.26 |
| 52W Range | $396.14 - $582.05 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.73 |
| Forward P/E | 12.0 |
| Current P/E | 12.9 |
| YoY Growth | 7.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 5.9% to 3.1% (-2.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.9pp (needs >4.0% for momentum thesis). MRS_5 (-0.2%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 4.1% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.69), confirming momentum. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: -DLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.06% (CS: 82) | Neutral |
| RSI_14 | 68.0 | Neutral |
| MACD Histogram | 1.69 | Bullish |
| vs SMA20 | 1.041x | Above |
| vs SMA50 | 1.061x | Above |
| vs SMA200 | 1.010x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $498.47
- **Stop Loss:** $479.77 (3.8% risk)
- **Target:** $517.17 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 48
- **Position Value:** $23,926.56
- **Portfolio %:** 23.93%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-28 (Est: $10.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.76 | $9.87 | +1.1% |
| 2025Q2 | $9.00 | $9.11 | +1.2% |
| 2025Q1 | $9.08 | $9.50 | +4.6% |
| 2024Q4 | $9.05 | $9.36 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*